← Leaderboards
Balaraman Kalyanaraman
Medical College Of Wisconsin
$20,398,607
Attributed
$27,185,232
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$27,185,232 · 14
By mechanism
R01$24,167,581 · 10
U01$2,568,769 · 1
P01$429,882 · 1
R13$19,000 · 2
Top collaborators
- Ming You11 shared
- Narayan G Avadhani5 shared
- Michael B Dwinell5 shared
- Anumantha Gounder Kanthasamy5 shared
- Laura A. Kresty5 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsApoptosisMitochondriaIn VivoInnovationMediatingGenerationsToxic EffectBaseNitric OxideMonitorProteinsMolecularAntioxidantsSignal TransductionTumorDoseDesignCytotoxicityPreventAnalogIn VitroOxidative StressImage
Grant awards (81)
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$383,989
R01 · FY2023 · CA
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$383,991
R01 · FY2022 · CA
Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol$523,684
R01 · FY2021 · CA
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$422,579
R01 · FY2021 · CA
Chemoprevention of lung cancer with mitochondria-targeted honokiol$115,136
R01 · FY2021 · CA
Chemoprevention of lung cancer with mitochondria-targeted honokiol$638,820
R01 · FY2020 · CA
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$382,111
R01 · FY2020 · CA
Chemoprevention of lung cancer with mitochondria-targeted honokiol$619,654
R01 · FY2019 · CA
CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver Disease$520,771
R01 · FY2019 · AA
Chemoprevention of lung cancer by targeting lonidamine to mitochondria$378,872
R01 · FY2019 · CA
Chemoprevention of lung cancer with mitochondria-targeted honokiol$627,013
R01 · FY2018 · CA
CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver Disease$520,771
R01 · FY2018 · AA
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$497,688
U01 · FY2018 · CA
Chemoprevention of lung cancer with mitochondria-targeted honokiol$620,971
R01 · FY2017 · CA
CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver Disease$520,771
R01 · FY2017 · AA
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$515,751
U01 · FY2017 · CA
CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver Disease$520,771
R01 · FY2016 · AA
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$506,653
U01 · FY2016 · CA
CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver Disease$534,637
R01 · FY2015 · AA
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$522,511
U01 · FY2015 · CA
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$526,166
U01 · FY2014 · CA
Mitochondria-targeted Agents in Breast Cancer$296,760
R01 · FY2014 · CA · contact PI
Neuroprotection by Mitochondria-targeted Antioxidants$510,053
R01 · FY2013 · NS · contact PI
Mitochondria-targeted Agents in Breast Cancer$287,582
R01 · FY2013 · CA · contact PI
Neuroprotection by Mitochondria-targeted Antioxidants$526,381
R01 · FY2012 · NS · contact PI
Mitochondria-targeted Agents in Breast Cancer$305,938
R01 · FY2012 · CA · contact PI
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells$304,932
R01 · FY2012 · CA · contact PI
Neuroprotection by Mitochondria-targeted Antioxidants$536,010
R01 · FY2011 · NS · contact PI
Nitric Oxide-Mediated Oxidation/Nitration in Membranes$361,089
R01 · FY2011 · HL · contact PI
Mitochondria-targeted Agents in Breast Cancer$305,938
R01 · FY2011 · CA · contact PI
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells$152,727
R01 · FY2011 · CA · contact PI
Neuroprotection by Mitochondria-targeted Antioxidants$557,341
R01 · FY2010 · NS · contact PI
Nitric Oxide-Mediated Oxidation/Nitration in Membranes$361,089
R01 · FY2010 · HL · contact PI
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells$314,363
R01 · FY2010 · CA · contact PI
Mitochondria-targeted Agents in Breast Cancer$308,201
R01 · FY2010 · CA · contact PI
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells$85,120
R01 · FY2010 · CA · contact PI
EPR 2010$5,000
R13 · FY2010 · CA · contact PI
Neuroprotection by Mitochondria-targeted Antioxidants$509,641
R01 · FY2009 · NS · contact PI
Nitric Oxide-Mediated Oxidation/Nitration in Membranes$361,089
R01 · FY2009 · HL · contact PI
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells$314,363
R01 · FY2009 · CA · contact PI
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells$85,097
R01 · FY2009 · CA · contact PI
Nitric Oxide-Mediated Oxidation/Nitration in Membranes$373,964
R01 · FY2008 · HL · contact PI
Role of iNOS, Nitric Oxide & Arginase in Statin-Mediated Toxicity in Cancer Cells$314,363
R01 · FY2008 · CA · contact PI
Bicarbonate Enhances Peroxidation of SOD/ALS Mutants$285,958
R01 · FY2008 · NS · contact PI
Role of Neuronal NOS & Superoxide in Neurodegeneration$328,901
R01 · FY2007 · NS · contact PI
Peroxide, NO and Iron Signaling in Endothelial Damage$284,454
R01 · FY2007 · HL · contact PI
Bicarbonate Enhances Peroxidation of SOD/ALS Mutants$278,286
R01 · FY2007 · NS · contact PI
Role of Neuronal NOS & Superoxide in Neurodegeneration$338,724
R01 · FY2006 · NS · contact PI
NITRIC OXIDE MEDICATED OXIDATION/NITRATION$292,950
R01 · FY2006 · HL · contact PI
Peroxide, NO and Iron Signaling in Endothelial Damage$292,950
R01 · FY2006 · HL · contact PI
Bicarbonate Enhances Peroxidation of SOD/ALS Mutants$287,218
R01 · FY2006 · NS · contact PI
eNOS & the Radical Mechanism of Antitumor Anthracyclines$256,332
R01 · FY2006 · CA · contact PI
Core--Free Radical Core Facility$217,840
P01 · FY2006 · HL · contact PI
Role of Neuronal NOS &Superoxide in Neurodegeneration$341,000
R01 · FY2005 · NS
Bicarbonate Enhances Peroxidation of SOD/ALS Mutants$325,895
R01 · FY2005 · NS
Peroxide, NO and Iron Signaling in Endothelial Damage$300,000
R01 · FY2005 · HL
NITRIC OXIDE MEDICATED OXIDATION/NITRATION$300,000
R01 · FY2005 · HL
eNOS &the Radical Mechanism of Antitumor Anthracyclines$262,500
R01 · FY2005 · CA
Core--Free Radical Core Facility$212,042
P01 · FY2005 · HL
Role of Neuronal NOS &Superoxide in Neurodegeneration$330,963
R01 · FY2004 · NS
NITRIC OXIDE MEDICATED OXIDATION/NITRATION$300,000
R01 · FY2004 · HL
Peroxide, NO and Iron Signaling in Endothelial Damage$300,000
R01 · FY2004 · HL
eNOS &the Radical Mechanism of Antitumor Anthracyclines$262,500
R01 · FY2004 · CA
NITRIC OXIDE MEDICATED OXIDATION/NITRATION$313,750
R01 · FY2003 · HL
Peroxide, NO and Iron Signaling in Endothelial Damage$287,500
R01 · FY2003 · HL
eNOS &the Radical Mechanism of Antitumor Anthracyclines$262,500
R01 · FY2003 · CA
ROLE OF NEURONAL NOS AND SUPEROXIDE IN NEURODEGENERATION$261,625
R01 · FY2003 · NS
BIOCARBONATE ENHANCES PEROXIDATION OF SOD/ALS MUTANTS$166,899
R01 · FY2003 · NS
ROLE OF NEURONAL NOS AND SUPEROXIDE IN NEURODEGENERATION$261,625
R01 · FY2002 · NS
eNOS &the Radical Mechanism of Antitumor Anthracyclines$250,000
R01 · FY2002 · CA
NITRIC OXIDE MEDIATED OXIDATION/NITRATION IN MEMBRANES$213,836
R01 · FY2002 · HL
BIOCARBONATE ENHANCES PEROXIDATION OF SOD/ALS MUTANTS$167,668
R01 · FY2002 · NS
ROLE OF NEURONAL NOS AND SUPEROXIDE IN NEURODEGENERATION$261,625
R01 · FY2001 · NS
NITRIC OXIDE MEDIATED OXIDATION/NITRATION IN MEMBRANES$207,608
R01 · FY2001 · HL
ENOS &THE RADICAL MECHANISM OF ANTITUMOR ANTHRACYCLINES$187,177
R01 · FY2001 · CA
BIOCARBONATE ENHANCES PEROXIDATION OF SOD/ALS MUTANTS$168,407
R01 · FY2001 · NS
ROLE OF NEURONAL NOS AND SUPEROXIDE IN NEURODEGENERATION$279,570
R01 · FY2000 · NS
BIOCARBONATE ENHANCES PEROXIDATION OF SOD/ALS MUTANTS$239,288
R01 · FY2000 · NS
NITRIC OXIDE MEDIATED OXIDATION/NITRATION IN MEMBRANES$201,562
R01 · FY2000 · HL
ENOS &THE RADICAL MECHANISM OF ANTITUMOR ANTHRACYCLINES$181,728
R01 · FY2000 · CA
OXYGEN RADICALS IN BIOLOGY GORDON CONFERENCE$14,000
R13 · FY2000 · ES